How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BL

NASDAQ:BLUE
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BL

bluebird bio IncNASDAQ BLUE Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is BLUE undervalued compared to its fair value?

The fair value of BLUE stock is hidden USD. Relative to the market price of 1.05 USD bluebird bio Inc is hidden.

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. The company is headquartered in Somerville, Massachusetts...[More about valuation]

bluebird bio Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.222 $B

Price:

1.05 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.657

FINANCIALS

bluebird bio financial for reporting period

Income Statement

0.012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.085 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.072 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.012 B 100%
0.0014 B 11%
-0.085 B -683%
-0.072 B -578%

Balance Sheet

0.61 B
0.22 B

Financial Position Analysis

Assets

0.61 B
Current Assets
0.25 B
Total non-current assets
0.37 B

Total current liabilities
0.16 B
Total non-current liabilities
0.23 B

Cash Flow Statement

-0.064 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.062 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

bluebird bio fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-34 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-124 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-14 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is BLUE attractive for investment based on fundamental analysis?

BLUE stock rating is hidden. bluebird bio is a hidden by Eyestock methodology.

Get BLUE Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-418

Gross Margin:

-11

CFO / Debt ratio:

hidden

Current ratio:

2.018

Debt / Equity ratio:

ROE:

-34

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BLUE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BLUE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

bluebird bio Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

bluebird bio Inc dividends

BLUE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BLUE stock

About the company bluebird bio Inc

Market cap $B

0.222

Dividend yield

Shares outstanding

102.923 B

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. The company is headquartered in Somerville, Massachusetts and currently employs 518 full-time employees. The company went IPO on 2013-06-19. The firm is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease (SCD), and elivaldogene autotemcel (eli-cel) as a treatment for cerebral adrenoleukodystrophy (CALD). The company is using a lentiviral vector (LVV) platform, it custom designs each of its therapies to address the underlying cause of disease. The firm is developing lovotibeglogene autotemcel (lovo-cel) as a one-time treatment for patients with SCD, a genetic disease caused by a single mutation in the B-globin gene that leads to the production of abnormal sickle hemoglobin (HbS). The BLA for betibeglogene autotemcel (beti-cel) is for B-thalassemia in patients who receive regular red blood cell (RBC) transfusions.

BLUE profile

  • Ticker

    BLUE

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    19 June 2013

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    518

  • City

    Somerville

  • Address

    455 Grand Union Boulevard

  • Cusip

    09609G100